# The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer

> **NCT05547529** · PHASE3 · RECRUITING · sponsor: **Blokhin's Russian Cancer Research Center** · enrollment: 156 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

- **PROCEDURE:** Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy.
- **PROCEDURE:** Patients undergoing neoadjuvant chemotherapy plus Ivory-Lewis or McKeown esophagectomy

## Key facts

- **NCT ID:** NCT05547529
- **Lead sponsor:** Blokhin's Russian Cancer Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-14
- **Primary completion:** 2025-09-14
- **Final completion:** 2027-09-14
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2022-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05547529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05547529, "The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05547529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*